Miller School Leads Groundbreaking Trial Treating Severe COVID-19 with Mesenchymal Stem Cells – University of Miami Miller School of Medicine

University of Miami Miller School of Medicine researchers led a unique and groundbreaking randomized controlled trial showing umbilical-cord derived mesenchymal stem cell infusions safely reduce risk of death and quicken time to recovery for the severest COVID-19 patients, according to results published in STEM CELLS Translational Medicine on January 5.
READ MORE

Can stem cells hasten COVID recovery and halt deaths? Miami study has positive results: – The Miami Herald

A faster recovery from the most severe of COVID-19 conditions? Fewer deaths from the novel coronavirus?
University of Miami Miller School of Medicine researchers hope those findings are a lasting result of a study UM led that used stem cells derived from umbilical cords to combat COVID. The COVID-umbilical study was published in January’s Stem Cells Translational Medicine journal.
READ MORE